Subscribe to RSS
Independent Predictors of Severity and Hospitalization in Acute Bronchiolitis: Neutrophil/Lymphocyte Ratio and Mean Platelet Volume
08 December 2017
29 April 2018
02 June 2018 (online)
Background and Aim Acute bronchiolitis is the most common cause of hospitalization in the first year of life. The neutrophil/lymphocyte ratio (NLR) and mean platelet volume (MPV) are readily calculable laboratory markers used to evaluate systemic inflammation. We aim to evaluate the optimal values of these markers for the prediction of severity and hospitalization in infants with acute bronchiolitis.
Materials and Methods A total of 105 patients with acute bronchiolitis and 62 healthy controls aged 1 to 12 months were prospectively enrolled to the study. The patients' group was classified into two groups, namely, outpatient and inpatient, also divided into three groups according to clinical scoring: mild, moderate, and severe. The association of NLR and MPV with clinical severity and hospitalization was investigated.
Results The mean age was 7.75 ± 2.98 months in patients and 7.69 ± 2.87 months in controls. The means of NLR were 0.47 and 0.64 in controls and patients, respectively (p = 0.032) and of MPV were 9.64 and 8.9 (p < 0.001), respectively. The means of NLR were 0.73 and 0.50 in inpatient and outpatient groups, respectively (p = 0.014) and of MPV were 8.65 and 9.32 (p = 0.046), respectively. NLR of 0.64 value was calculated as a cutoff for the prediction of hospitalization with 45% sensitivity and 83% specificity (positive predictive value = 81%, negative predictive value = 19%).
Conclusion We found that blood neutrophil percentage and blood NLR are increased and also weakly predictive—but insufficient to be clinically useful—for the decision of hospitalization in acute bronchiolitis. When the positive predictive value of an NLR of 0.64 is sufficient to decide hospitalization, the negative predictive value is impractical. MPV value was less in infants with acute bronchiolitis than healthy controls and in inpatients than outpatients with acute bronchiolitis. Low MPV might be marker of inflammation in acute bronchiolitis.
- 1 Ralston SL, Lieberthal AS, Meissner HC. , et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014; 134 (05) e1474-e1502 . Pediatrics 2015;136(4):782
- 2 Maguire C, Cantrill H, Hind D, Bradburn M, Everard ML. Hypertonic saline (HS) for acute bronchiolitis: systematic review and meta-analysis. BMC Pulm Med 2015; 15: 148
- 3 Wang EE, Law BJ, Boucher FD. , et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1996; 129 (03) 390-395
- 4 Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420 (6917): 860-867
- 5 Rueda-Clausen CF, Lopez-Jaramillo P, Luengas C. , et al. Inflammation but not endothelial dysfunction is associated with the severity of coronary artery disease in dyslipidemic subjects. Mediators Inflamm 2009; DOI: 10.1155/2009/469169.
- 6 Bhat T, Teli S, Rijal J. , et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 2013; 11 (01) 55-59
- 7 Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 2013; 88 (01) 218-230
- 8 Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009; 30 (07) 1073-1081
- 9 Azab B, Shah N, Akerman M, McGinn Jr JT. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012; 34 (03) 326-334
- 10 Kisacik B, Tufan A, Kalyoncu U. , et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008; 75 (03) 291-294
- 11 Kapsoritakis AN, Koukourakis MI, Sfiridaki A. , et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Am J Gastroenterol 2001; 96 (03) 776-781
- 12 Bria M, Coates LEC. Wheezing in infants: bronchiolitis. In: Kliegman RM. , ed. Nelson Textbook of Pediatrics. 20th ed. Philadelphia: Elsevier; 2016: 2044-2050
- 13 Seyyah BA. The investigation of surfactant protein B and D gens polymorphisms in infants with acute bronchiolitis. Tokat TURKEY: Gaziosmanpasa University; 2016
- 14 Steiner RW. Treating acute bronchiolitis associated with RSV. Am Fam Physician 2004; 69 (02) 325-330
- 15 Curbelo J, Luquero Bueno S, Galván-Román JM. , et al. Inflammation biomarkers in blood as mortality predictors in community-acquired pneumonia admitted patients: importance of comparison with neutrophil count percentage or neutrophil-lymphocyte ratio. PLoS One 2017; 12 (03) e0173947
- 16 Bozdemir SE, Altintop YA, Uytun S, Aslaner H, Torun YA. Diagnostic role of mean platelet volume and neutrophil to lymphocyte ratio in childhood brucellosis. Korean J Intern Med 2017; 32 (06) 1075-1081
- 17 Özer S, Yılmaz R, Sönmezgöz E. , et al. Simple markers for subclinical inflammation in patients with familial Mediterranean fever. Med Sci Monit 2015; 21: 298-303
- 18 Yazici M, Özkisacik S, Öztan MO, Gürsoy H. Neutrophil/lymphocyte ratio in the diagnosis of childhood appendicitis. Turk J Pediatr 2010; 52 (04) 400-403
- 19 Sakallı H, Kal O. Mean platelet volume as a potential predictor of proteinuria and amyloidosis in familial Mediterranean fever. Clin Rheumatol 2013; 32 (08) 1185-1190
- 20 Makay B, Türkyilmaz Z, Ünsal E. Mean platelet volume in children with familial Mediterranean fever. Clin Rheumatol 2009; 28 (08) 975-978
- 21 Ergül AB, Torun YA, Uytun S, Aslaner H, Kısaaslan AP, Şerbetçi MC. Reduction in mean platelet volume in children with acute bronchiolitis. Turk Pediatri Ars 2016; 51 (01) 40-45
- 22 Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation?. Curr Pharm Des 2011; 17 (01) 47-58
- 23 Clarke D, Johnson PW, Banks RE. , et al. Effects of interleukin 6 administration on platelets and haemopoietic progenitor cells in peripheral blood. Cytokine 1996; 8 (09) 717-723